Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Online Naloxone Training and Distribution for Opioid Users
NCT04303000Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2021
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of naloxone in opioid overdose, sponsored by University of Alabama at Birmingham. Primary endpoints: Number of Participants That Completed the Training at 6 months and Change in Participant Knowledge of Opioid Overdose Response Procedures at 6 months. Started Jul 2021; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT04303000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303000.